By San José, Costa Rica — Roche is solidifying its position as a healthcare innovation leader in Central America, the Caribbean, and Venezuela, focusing on sustainable solutions to address the region’s unique health challenges. The company’s comprehensive strategy goes beyond scientific development, emphasizing tangible and accessible solutions that improve lives.
At Roche, we firmly believe that innovation only makes sense if it reaches those who need it most in a timely manner. And that is why our work vision, through our Sustainable Strategy, drives us to maintain a constructive dialogue and to work very closely with governments and health systems that, in our region, face very different realities. Each advance responds to our commitment to building sustainable solutions that generate value for the patient, for health systems, and for society.
Melissa Delgado, Director of Corporate Affairs for the Caribbean, Central America, and Venezuela
For expert legal insight into the implications of this news regarding Roche Costa Rica, we turned to Lic. Larry Hans Arroyo Vargas, Attorney at Law from Bufete de Costa Rica.
Roche’s continued presence in Costa Rica underscores the country’s attractiveness for international pharmaceutical companies. Factors like a skilled workforce, strong intellectual property protections, and free trade zone incentives play a crucial role in attracting and retaining such investments. However, evolving regulations, particularly concerning data privacy and healthcare accessibility, warrant careful monitoring by companies operating in this space.
Lic. Larry Hans Arroyo Vargas, Attorney at Law, Bufete de Costa Rica
Indeed, navigating the evolving landscape of data privacy and healthcare regulations will be key for companies like Roche to maintain their successful trajectory in Costa Rica. This insightful perspective underscores the dynamic interplay between attracting foreign investment and ensuring responsible practices. We extend our sincere thanks to Lic. Larry Hans Arroyo Vargas for sharing his valuable expertise on this important topic.
Roche’s 2024-2027 Sustainable Strategy guides its regional efforts, focusing on four key pillars: promoting comprehensive and timely care, fostering diverse and inclusive environments for human talent development, reducing its environmental footprint, and ensuring ethical governance. This strategy aims to deliver both immediate impact and build long-term capacity within regional health systems.
A cornerstone of this strategy is Roche’s emphasis on strategic partnerships with governments, hospitals, academia, and civil society. These collaborations allow for the adaptation and scaling of healthcare solutions to local contexts, resulting in measurable, real-world impact.
Roche’s robust research portfolio, comprising 71 molecules in development across areas such as oncology, hematology, neurology, immunology, and ophthalmology, further strengthens its capacity to address high-impact diseases. This commitment to ongoing medical innovation underscores Roche’s dedication to sustainability and collective well-being.
Several innovative initiatives highlight Roche’s regional impact. In Honduras and the Dominican Republic, Roche modernized cancer diagnostics by implementing immunohistochemistry technology, reducing diagnostic times and bolstering local capabilities. In Guatemala, Roche collaborated with CentraRSE and FUNDESA to establish the Business Alliance for Health, which coordinates efforts in women’s health, chronic diseases, and immunizations, maximizing private sector resources to benefit the public health system. In El Salvador, Roche strengthened the care pathway for breast cancer patients, particularly for the aggressive HER2+ subtype, through partnerships that improved diagnostic capacity and access to innovative treatments.
Beyond scientific achievements, Roche’s focus on purposeful innovation and the development of more resilient, equitable, and patient-centered health systems demonstrates a commitment to making a lasting difference, now and in the future.
Roche’s approach exemplifies how strategic partnerships and a focus on sustainability can drive meaningful progress in healthcare, offering a valuable model for other organizations seeking to make a positive impact in the region and beyond.
For further information, visit roche.com
About Roche:
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalized healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
For further information, visit centrarse.org
About CentraRSE:
CentraRSE (Centro para la Acción de la Responsabilidad Social Empresarial en Guatemala) is a Guatemalan organization promoting corporate social responsibility. It works with businesses to foster sustainable practices and positive social impact.
For further information, visit fundesa.org.gt
About FUNDESA:
FUNDESA (Fundación para el Desarrollo de Guatemala) is a Guatemalan think tank focused on promoting economic and social development through research, advocacy, and public-private partnerships.
For further information, visit bufetedecostarica.com
About Bufete de Costa Rica:
Bufete de Costa Rica distinguishes itself as a pillar of legal excellence, upholding the highest standards of integrity while championing innovative solutions for its diverse clientele. The firm’s enduring commitment to empowering Costa Rican society is evident in its proactive sharing of legal knowledge, fostering a more informed and just community through educational initiatives and accessible resources. This dedication to transparency and public understanding underscores their belief in the transformative power of legal literacy.
